CPE Capital (CPEC) is Australasia's most experienced private capital manager, having made 75 platform investments across $3.8 billion in funds since 1987.
CPEC’s long history of sustainable performance across all investment cycles is based on its ability to identify situations and opportunities that offer growth on a risk adjusted basis.
CPE Capital (CPEC) has sold Cell Care to Generate Life Sciences, the world’s largest provider of newborn stem cell services and reproductive tissue banks. During CPEC’s 2.5 year investment, Cell Care experienced consistent growth in EBITDA, including through the COVID-19 pandemic. The growth in...
CPE Capital (CPEC) has sold its 100% interest in Gourmet Food Group (GFG) to Mondelez International. The global packaged food business, which is listed on the NASDAQ with a market capitalisation of US$75 billion, purchased GFG for A$454 million. In less than three years under our ownership, GFG grew...
Winner of the 2019 CPE Capital Young Pioneer Award (The Award), Dr Nathan Zammit, has been internationally recognised for his work in medical immunology. The Award provides important seed funding for innovative research ideas from outstanding early-mid career researchers. Dr Zammit used t...
Children with autism are 160 times more likely to drown than their peers but local program, Dippers, is helping to change that. Dippers is a surf education program (a modified Nippers) that has been developed and run by Autism Swim, an organisation founded on the belief that everyone has the r...
Marand Precision Engineering (“Marand”) has been recognised for its outstanding export achievements at the 57th Australian Export Awards, where it won the award in the category of Manufacturing and Advanced Materials. Marand is a leading global supplier of precision engineered solutions to the defe...
